Possible role of human interleukin-6 and soluble interleukin-6 receptor in hepatitis B virus infection (Q45737156)

15 December 2017

Possible role of human interleukin-6 and soluble interleukin-6 receptor in hepatitis B virus infection (English)

1 reference

15 December 2017

0 references

1 reference

Heinz D

1

1 reference

15 December 2017

Peters M

2

1 reference

15 December 2017

Prange R

3

1 reference

15 December 2017

Gerken G

4

1 reference

15 December 2017

Rose-John S

5

1 reference

15 December 2017

1 May 2001

1 reference

Journal of Viral Hepatitis

15 December 2017

1 reference

15 December 2017

8

1 reference

15 December 2017

3

1 reference

15 December 2017

186-193

1 reference

The discovery of the hepatitis viruses

15 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00281.X

Cells transfected with human interleukin 6 cDNA acquire binding sites for the hepatitis B virus envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00281.X

Search for hepatitis B virus cell receptors reveals binding sites for interleukin 6 on the virus envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00281.X

Human interleukin-6 facilitates hepatitis B virus infection in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00281.X

Sequence-specific repression of cotranslational translocation of the hepatitis B virus envelope proteins coincides with binding of heat shock protein Hsc70.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00281.X

Organ and species specificity of hepatitis B virus (HBV) infection: a review of literature with a special reference to preferential attachment of HBV to human hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00281.X

The asialoglycoprotein receptor mediates hepatic binding and uptake of natural hepatitis B virus particles derived from viraemic carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00281.X

Endonexin II, present on human liver plasma membranes, is a specific binding protein of small hepatitis B virus (HBV) envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00281.X

The putative cell receptors for hepatitis B virus (HBV), annexin V, and apolipoprotein H, bind to lipid components of HBV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00281.X

Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00281.X

Transfection of a rat hepatoma cell line with a construct expressing human liver annexin V confers susceptibility to hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00281.X

Receptor-mediated entry of hepatitis B virus particles into liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00281.X

Human hepatitis B virus enhancer 1 is responsive to human interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00281.X

Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/soluble IL-6 receptor double-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00281.X

Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00281.X

10.1046/J.1365-2893.2001.00281.X

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

1 reference